NCT07072546

Brief Summary

This study aims to evaluate the effects of chitosan and injectable platelet-rich fibrin (i-PRF) on wound healing at the donor site following free gingival graft (FGG) procedures. The palatal donor area often experiences delayed healing and postoperative discomfort, motivating the search for effective biomaterials to enhance recovery and reduce patient morbidity. Although various approaches have been investigated, the combined application of chitosan and i-PRF has not yet been explored in this context. The study examines three patient groups treated at the periodontology departments of Çukurova and Biruni University: one with gelatin sponge (control), one with chitosan, and one with chitosan infused with i-PRF. Parameters such as pain (VAS), bleeding, burning sensation, dietary changes, epithelialization (PEHI score), and color match were assessed over a 2-month follow-up. The findings are expected to provide insights into whether i-PRF-enhanced chitosan offers superior healing outcomes and greater patient comfort compared to conventional methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

July 12, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2025

Completed
Last Updated

January 27, 2026

Status Verified

January 1, 2026

Enrollment Period

5 months

First QC Date

July 7, 2025

Last Update Submit

January 26, 2026

Conditions

Outcome Measures

Primary Outcomes (4)

  • Palatal early healing index

    The palatal early healing index (PEHI) measured the following 5 parameters: (1) bleeding on palpation, which was assessed with a damp cotton applicator gently rolled on the wound site; (2) incomplete epithelialization (assessed intraorally by the visual presence or absence of immediate bubble formation after hydrogen peroxide application with sterile gauze on the wound area); (3) presence of redness assessed intraorally; (4) presence of swelling assessed intraorally; and (5) presence of granulation tissue assessed intraorally. Each of the 5 parameters was assessed dichotomously (yes/no).

    Day 7

  • Palatal early healing index

    The palatal early healing index (PEHI) measured the following 5 parameters: (1) bleeding on palpation, which was assessed with a damp cotton applicator gently rolled on the wound site; (2) incomplete epithelialization (assessed intraorally by the visual presence or absence of immediate bubble formation after hydrogen peroxide application with sterile gauze on the wound area); (3) presence of redness assessed intraorally; (4) presence of swelling assessed intraorally; and (5) presence of granulation tissue assessed intraorally. Each of the 5 parameters was assessed dichotomously (yes/no).

    Day 14

  • Palatal early healing index

    The palatal early healing index (PEHI) measured the following 5 parameters: (1) bleeding on palpation, which was assessed with a damp cotton applicator gently rolled on the wound site; (2) incomplete epithelialization (assessed intraorally by the visual presence or absence of immediate bubble formation after hydrogen peroxide application with sterile gauze on the wound area); (3) presence of redness assessed intraorally; (4) presence of swelling assessed intraorally; and (5) presence of granulation tissue assessed intraorally. Each of the 5 parameters was assessed dichotomously (yes/no).

    Day 28

  • Palatal early healing index

    The palatal early healing index (PEHI) measured the following 5 parameters: (1) bleeding on palpation, which was assessed with a damp cotton applicator gently rolled on the wound site; (2) incomplete epithelialization (assessed intraorally by the visual presence or absence of immediate bubble formation after hydrogen peroxide application with sterile gauze on the wound area); (3) presence of redness assessed intraorally; (4) presence of swelling assessed intraorally; and (5) presence of granulation tissue assessed intraorally. Each of the 5 parameters was assessed dichotomously (yes/no).

    Day 56

Secondary Outcomes (33)

  • Palatal Pain score

    Day 1

  • Palatal Pain score

    Day 3

  • Palatal Pain score

    Day 7

  • Palatal Pain score

    Day 14

  • Palatal Pain score

    Day 28

  • +28 more secondary outcomes

Study Arms (3)

control

OTHER

control group

Procedure: free gingival graft + gelatin sponge

chitosan

ACTIVE COMPARATOR
Procedure: free gingival graft + chitosan

chitosan-iprf

EXPERIMENTAL
Procedure: free gingival graft + chitosan and i-PRF

Interventions

free gingival graft surgery and application of chitosan and i-PRF to the palatal wound

chitosan-iprf

Free gingival graft surgery and application of gelatin sponge to the palatal wound

control

free gingival graft surgery and application of chitosan to the palatal wound

chitosan

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Periodontally healthy
  • Having good oral hygiene (plaque accumulation \<20%)
  • Requiring a free gingival graft (FGG) procedure in an area with insufficient keratinized gingiva width (\<2 mm)

You may not qualify if:

  • Having systemic diseases contraindicating surgical procedures,
  • Uncontrolled diabetes (HbA1c \> 7),
  • Being pregnant or breastfeeding,
  • Autoimmune and/or inflammatory diseases of the oral cavity,
  • Active periodontal disease,
  • Smokers (≥ 10 cigarettes per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cukurova University

Adana, Turkey (Türkiye)

Location

Biruni University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Chitosanproliferation regulatory factors, human urine

Intervention Hierarchy (Ancestors)

ChitinBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

July 7, 2025

First Posted

July 18, 2025

Study Start

July 12, 2025

Primary Completion

December 10, 2025

Study Completion

December 10, 2025

Last Updated

January 27, 2026

Record last verified: 2026-01

Locations